---
schema_version: "secwatch.filing_event.v1"
accession: "0001790340-24-000073"
form_type: "8-K/A"
ticker: "IMRX"
cik: "0001790340"
company_name: "Immuneering Corp"
filed_at: "2024-10-02T23:59:59+00:00"
generated_at: "2026-05-30T22:45:44.011038+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Immuneering appoints Dr. Thomas Schall to Compensation Committee effective Oct 1, 2024

## Summary
- Dr. Thomas Schall appointed to Compensation Committee of Board, effective Oct 1, 2024.
- Previous election as Class I director on March 11, 2024; committee assignment now settled.
- Appointment follows recommendation of Nominating and Corporate Governance Committee.

## SEC filing metadata
- accession: 0001790340-24-000073
- form_type: 8-K/A
- ticker: IMRX
- cik: 0001790340
- company_name: Immuneering Corp
- filed_at: 2024-10-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1790340/000179034024000073/0001790340-24-000073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1790340/000179034024000073/imrx-20240311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001790340-24-000073
- JSON: https://secwatch.observer/filing/0001790340-24-000073.json
- Plain text: https://secwatch.observer/filing/0001790340-24-000073.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.